The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer.
Age: 18 years - 66+
Gender: Male
We've found 1 total result for "BulboSpinal Atrophy XLinked".